8MV0 — Bioharvest Sciences Cashflow Statement
0.000.00%
Last trade - 00:00- €82.51m
- €74.94m
- $34.51m
Annual cashflow statement for Bioharvest Sciences, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -9.83 | -11.2 | -12.6 | -12.9 | -11.1 |
| Depreciation | |||||
| Non-Cash Items | 2.88 | 1.73 | 2.98 | 5.53 | 4.23 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.232 | -0.449 | 0.223 | -0.555 | -1.94 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Accounts Payable | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -6.79 | -9.24 | -8.52 | -6.68 | -7.23 |
| Capital Expenditures | -1.64 | -1.26 | -1.47 | -2.83 | -2.35 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | — | — | — | -0.192 | -0.01 |
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -1.64 | -1.26 | -1.47 | -3.03 | -2.37 |
| Financing Cash Flow Items | — | -0.038 | — | — | -0.159 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 10.8 | 8.14 | 13.6 | 6.78 | 30.2 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 2.33 | -2.38 | 3.62 | -2.96 | 20.6 |